Oligomers of β-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model

Amyloid plaque deposition in the brain is a hallmark of Alzheimer's disease, but recent evidence indicates that the disease may be primarily caused by soluble amyloid-beta (1-42) (Abeta) oligomers or Abeta-derived diffusible ligands (ADDLs). ADDLs induce cognitive deficits in animal models and are thought to assemble in vitro by a mechanism apart from plaque formation. To investigate the in vivo relationship of ADDLs and plaques, biotin-labeled ADDLs (bADDLs) or amylin oligomers (bAMs) were injected into the hippocampus of hAPP overexpressing mice. The brains were collected 1 or 5 weeks after the last treatment and were processed for immunohistochemistry. Staining of tissue 1 week post-treatment showed bADDLs had diffused throughout the tissue and incorporated into plaques. Additionally, small deposits of thioflavin S-negative bADDLs were observed. At 5 weeks post-treatment, thioflavin S-positive material continued to accumulate around plaques containing bADDLs. Thioflavin S-positive material also accrued around bADDL deposits, implying that bADDLs were capable of seeding new plaques. In contrast, bAMs cleared from the brain and did not accumulate in plaques. Together, these data indicate that ADDLs are able to contribute to in vivo plaque formation in a peptide-specific manner.

[1]  P. Keller,et al.  Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .

[2]  Chan Beum Park,et al.  Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[3]  H. Mori,et al.  Absence of synaptophysin near cortical neurons containing oligomer Aβ in Alzheimer's disease brain , 2006, Journal of neuroscience research.

[4]  P. Lansbury,et al.  The C‐Terminus of the β Protein is Critical in Amyloidogenesis a , 1993 .

[5]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[6]  J. Jhamandas,et al.  Antagonist of the Amylin Receptor Blocks β-Amyloid Toxicity in Rat Cholinergic Basal Forebrain Neurons , 2004, The Journal of Neuroscience.

[7]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[8]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[9]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Frautschy,et al.  Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo , 2004, Neurobiology of Aging.

[11]  A. Roher,et al.  Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice , 2000, The Journal of Neuroscience.

[12]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Levine,et al.  Modeling Alzheimer's disease and other proteopathies in vivo: Is seeding the key? , 2002, Amino Acids.

[14]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[15]  R. Glockshuber,et al.  Amyloid-β Aggregation , 2007, Neurodegenerative Diseases.

[16]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[17]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[18]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[19]  S. Barghorn,et al.  Aβ-globulomers are formed independently of the fibril pathway , 2008, Neurobiology of Disease.

[20]  S. Wiegand,et al.  Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology , 1986, Peptides.

[21]  J. Bureš,et al.  β-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or β-amyloid deposits , 2006 .

[22]  D. Walsh,et al.  Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host , 2006, Science.

[23]  George A. Carlson,et al.  The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[24]  W. Klein,et al.  Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.

[25]  W. Klein,et al.  Why Alzheimer’s is a disease of memory: The attack on synapses by Aß oligomers (ADDLs) , 2008, The journal of nutrition, health & aging.

[26]  R. Hepler,et al.  Solution State Characterization of Amyloid β-Derived Diffusible Ligands , 2006 .

[27]  D. Hanger,et al.  Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Trojanowski,et al.  Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain , 1997, The Journal of Neuroscience.

[29]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Götz,et al.  Human but not rat amylin shares neurotoxic properties with Aβ42 in long‐term hippocampal and cortical cultures , 2008, FEBS letters.

[31]  W. Klein,et al.  Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease , 2006, Journal of Biological Chemistry.

[32]  Expression in brain of amyloid precursor protein mutated in the alpha‐secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. , 1996 .

[33]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[34]  A. Roher,et al.  Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic mice , 2002, Peptides.

[35]  B. Hyman,et al.  Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.

[36]  Y. Ko,et al.  Amyloid β oligomerization is induced by brain lipid rafts , 2006 .

[37]  E. Chen-Dodson,et al.  Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons , 2010, Neurobiology of Aging.

[38]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[39]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[40]  D. Teplow,et al.  Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.

[41]  P. Fraser,et al.  Structural Transitions Associated with the Interaction of Alzheimer β-Amyloid Peptides with Gangliosides* , 1998, The Journal of Biological Chemistry.

[42]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[43]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[44]  U. Aebi,et al.  Human Amylin Oligomer Growth and Fibril Elongation Define Two Distinct Phases in Amyloid Formation* , 2004, Journal of Biological Chemistry.

[45]  M. Findeis.  The role of amyloid β peptide 42 in Alzheimer's disease , 2007 .

[46]  R. Ridley,et al.  Very long term studies of the seeding of β-amyloidosis in primates , 2006, Journal of Neural Transmission.